For the latest inventions regarding cannabis, one has to look at Israel. They were the first to isolate THC and CBD, for example, and were also the first to ever catch on to the famous entourage effect of cannabis.
Now the company BioHarvest Technology claims they can clone the cells of cannabis – not the plant as a whole – in a bioreactor, with the result that the active components we know and love so much can be up to twelve times stronger!
Read more about cloned cannabis cells and find the latest hemp news of the day with the Hemp.im mobile app.
Cannabis plants are not grown at all
‘Cloned cannabis cells with 12 times more potency are grown in Israeli bioreactor,’ headlines The Times Of Israel newspaper about the latest homegrown cannabis invention. Now, of course, we have known the term “cloning” for many years in the cannabis world, but that’s not what this is about. “We don’t grow the plant at all,” said BioHarvest CEO Ilan Sobel firmly.
No, in this case, it is exclusively about cloning the cells of the cannabis plant. These are cultivated in a powdery biomass that contains all the active components of cannabis, which can thus be boosted up to twelve times the strength! Short story long, cloning at the cellular level rather than at the plant level. Additional advantage according to the Israeli company is the much less waste.
BioHarvest is only interested in the trichomes in the buds
BioHarvest Technology’s CEO explained the exact benefits of their invention, intended primarily for the manufacture of medicinal cannabis products. Ilan Sobel: “Cannabis plants are largely grown for their flowers. The flower contains the essential trichomes that are the source of cannabinoids, terpenes, and flavonoids. Our technology makes it possible to grow cannabis cells in bioreactors with 93 percent trichomes.”
Cannabis – or rather cannabis cells – grown with biomass in bioreactors has 93 percent trichomes, is full-spectrum and you can “control” the cannabis for all levels/proportions of cannabinoids, terpenes, and flavonoids. The external presentation is still being worked on (hopefully)….
Growing cannabis in a bioreactor?!
Biomass is obviously not grown the way cannabis plants are normally grown, instead, it is produced in a bioreactor. And so that’s why, as the CEO said, not a single cannabis plant is grown nor harvested at BioHarvest. “We grow them in huge bioreactors in just three weeks – while regular cannabis takes 14 to 23 weeks. Our technique is also able to significantly increase the levels of active ingredients, as a percentage by weight versus what is normally found in the plant,” Sobel proudly proclaimed.
The many benefits of cloned cannabis cells
Less to no waste because you don’t have a plant but cells from the plant, higher percentages of cannabinoids, terpenes, and flavonoids – the active ingredients in cannabis – a trichome content of as much as 93 percent, and the whole mess is also ready in just three weeks. You need 90 percent less space for it and it can do it quite a bit cheaper than the traditional method of cultivation, i.e. with plants.
Yes, according to the inventors, clone cannabis cells’ biomass requires much less water and nutrition than plants. Also handy these days. And for the grower on duty, this method allows him/her to avoid contamination and infections. You also avoid the “variation in cannabis components that nature dictates in plants.
In addition, for the end user, either consumer or patient, the “bitter taste of plant material” is significantly reduced.
Creative with biomass and bioreactor
How do they do it? The bioscientists are able to jack up the potency by tinkering with the conditions inside the bioreactor. “By adjusting specific conditions the cells are exposed to, we can create different desired compositions of active ingredients. That means we can scale up and scale down between the various cannabinoids.”
Needless to say, BioHarvest does not reveal to the media in detail exactly how their patented technology – called Bio-Plant CELLicitation™ – works. What they do say is that they have the power to increase potency 12 times, simply by changing the environment inside the bioreactor.
The CEO of BioHarvest Technology, Mr. Ilan Sobel, even gets somewhat philosophical about their cannabis plant cell cloning invention at the end of the interview with The Times Of Israel. And that makes for a fine bouncer to this no-Frankenstein-but-somewhat-science-fiction article.
“The bottom line is that we can make cannabis and hemp far more useful than before, at lower cost to our planetary resources. It is a wellness and sustainability solution from Israel that can provide a truly inspiring contribution to the world.”
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in CNNBS, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
How Much Do We Know About Sustainability: The ESG Culture LAB Report
From the results that emerge from the Eikon Italia survey, although citizens have only a partial vision of sustainability, more...
How a Newly Launched Bitcoin ETF Is Seen by Investors
The Bitcoin ETF Token (BTCETF) is a project issued on the Ethereum blockchain. Its native token is BTCETF and is...
Walliance Buys Lymo, the First French Real Estate Crowdfunding Platform
Walliance, with the inclusion of Lymo Finance, has solidified its position with over €160 million transacted, boasting around 98,000 registered...
Mediquo Is Committed to the International Market and Aims to Double Sales in 2024
Mediquo makes it possible for any healthcare professional to care for their patients via chat. Last April, the Catalan company...
Why the Agrifood Industry in Morocco is a Strategic Challenge
The organization of an international agrifood trade show in Morocco would be a key lever for stimulating local exports and...
Impact Investing2 weeks ago
New Round for 3rd Edition Dedicated to High-Impact Startups in Italy
Fintech6 days ago
Private Credit and Tokenization: a Market Worth Over $1 Trillion
Cannabis1 week ago
Canada’s Green Gold: Cannabis Sales Bring $60 Million for Health Minister
Crowdfunding3 days ago
Innexta and Assofintech Event Gathers 200 Investors to Meet Live Crowdinvesting Portals